GE HealthCare Debuts AI-Powered Solution for Radiation Therapy

GE HealthCare announced updates to Intelligent Radiation Therapy (iRT), a new version of the company’s software for radiation workflow management. It was designed to cut the time for patients to go from diagnosis to treatment.

The iRT solution is artificial intelligence (AI)-supported by GE HealthCare and third-party applications—the latest features provide enhanced connectivity to systems that radiation oncology departments use most and use insights to boost departmental efficiency.

The company also revealed a new capability for theranostics that manages complex workflows throughout the patient’s journey to extend its expertise in radiation therapy workflows. The updates will be showcased at this year’s American Society for Radiation Oncology (ASTRO) annual meeting for the first time.

New features include analytics reporting to give administrators a holistic view to assess efficiency, identify operational gaps, and document trends. A staff scheduler accounts for out of office schedules using and intelligent resource management tool.

Organs at risk are auto-segmented by MR Contour DL, which uses AI to outline sensitive organs near a tumor so they can be protected during treatment. iRT enabled connection with a GE HealthCare-developed AI model, MR Contour DL, for MR imaging and is interoperable with third-party devices MVision Contour+ for CT imaging.

The VERT virtual reality app from Vertual connects to a third-party application that lets clinicians walk patients through a simulation of the treatment process and uses advanced 3D models for staff training.

“We are transforming the radiation therapy experience for patients and clinicians with our Intelligent Radiation Therapy solution, helping clinicians move from diagnosis to treatment in minutes, not days,” said Ben Newton, GE HealthCare’s general manager for Oncology Solutions. “We’re thrilled to share the latest features in iRT designed to bring greater precision, efficiency, and personalization to cancer care.”

Introducing iRT for theranostics

Theranostics is a branch of nuclear medicine that uses molecular imaging and targeted radionuclide therapies aimed at the same biological target to treat cancer in the body and is gaining interest for advanced-stage cancer outcomes. These therapeutic and diagnostic technologies work together to enable a personalized, highly precise, patient-centric approach to medical diagnosis and treatment.

The iRT features for theranostics aim to bring a unified view to this complex treatment. It integrates with EMRs and OIS to give a holistic view of the patient journey and guide clinicians step-by-step through patient intake, patient assessment, scheduling, medication dosing, dosimetry, and clinical reviews.